EDP Sciences logo
Search
Menu
All issues Volume 38 / No 6 (November-December 2007) Vet. Res., 38 6 (2007) 819-834 References
Free Access
Issue
Vet. Res.
Volume 38, Number 6, November-December 2007
Page(s) 819 - 834
DOI https://doi.org/10.1051/vetres:2007037
Published online 31 August 2007
How to cite this article Vet. Res. (2007) 819-834
References of  Vet. Res. 38 (2007) 819-834
  1. Baker J.C., The clinical manifestations of bovine viral diarrhea infection, Vet. Clin. North Am. Food Anim. Pract. (1995) 11:425-445 [PubMed].
  2. Barouch D., Rational design of gene-based vaccines, J. Pathol. (2006) 208:283-289 [PubMed].
  3. Baxi M.K., Deregt D., Robertson J., Babiuk L.A., Schlapp T., Tikoo S.K., Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats, Virology (2000) 278:234-243 [CrossRef] [PubMed].
  4. Becher P., Orlich M., Thiel H.J., Complete genomic sequence of border disease virus, a pestivirus from sheep, J. Virol. (1998) 72:5165-5173 [PubMed].
  5. Bevilacqua A., Ceriani M.C., Capaccioli S., Nicolin A., Post-transcriptional regulation of gene expression by degradation of messenger RNAs, J. Cell. Physiol. (2003) 195:356-372 [PubMed].
  6. Bolin S.R., Immunogens of bovine viral diarrhea virus, Vet. Microbiol. (1993) 37:263-271 [CrossRef] [PubMed].
  7. Bolin S.R., Ridpath J.F., Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides limited protection from systemic infection and disease, Arch. Virol. (1996) 141:1463-1477 [CrossRef] [PubMed].
  8. Boxus M., Tignon M., Roels S., Toussaint J.F., Walravens K., Benoit M.A., Coppe P., Letesson J.J., Letellier C., Kerkhofs P., DNA immunization with plasmids encoding fusion and nucleocapsid proteins of BRSV induces a strong cell-mediated immunity and protects calves against challenge, J. Virol. (2007) 81:6879-6889 [CrossRef] [PubMed].
  9. Boulanger D., Waxweiler S., Karelle L., Loncar M., Mignon B., Dubuisson J., Thiry E., Pastoret P.P., Characterization of monoclonal antibodies to bovine viral diarrhoea virus: evidence of a neutralizing activity against gp48 in the presence of goat anti-mouse immunoglobulin serum, J. Gen. Virol. (1991) 72:1195-1198 [PubMed].
  10. Brunak S., Engelbrecht J., Knudsen S., Prediction of human mRNA donor and acceptor sites from the DNA sequence, J. Mol. Biol. (1991) 220:49-65 [CrossRef] [PubMed].
  11. Bruschke C.J., Moormann R.J., van Oirschot J.T., van Rijn P.A., A subunit vaccine based on glycoprotein E2 of bovine virus diarrhea virus induces fetal protection in sheep against homologous challenge, Vaccine (1997) 15:1940-1945 [CrossRef] [PubMed].
  12. Bruschke C.J., van Oirschot J.T., van Rijn P.A., An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep, Vaccine (1999) 17:1983-1991 [CrossRef] [PubMed].
  13. Collen T., Morrison W.I., CD4(+) T-cell responses to bovine viral diarrhoea virus in cattle, Virus Res. (2000) 67:67-80 [CrossRef] [PubMed].
  14. Collen T., Carr V., Parsons K., Charleston B., Morrison W.I., Analysis of the repertoire of cattle CD4(+) T cells reactive with bovine viral diarrhoea virus, Vet. Immunol. Immunopathol. (2002) 87:235-238 [PubMed].
  15. Couvreur B., Letellier C., Collard A., Quenon P., Dehan P., Hamers C., Pastoret P.-P., Kerkhofs P., Genetic and antigenic variability in bovine viral diarrhea virus (BVDV) isolates from Belgium, Virus Res. (2002) 85:17-28 [CrossRef] [PubMed].
  16. De Moerlooze L., Lecomte C., Brown-Shimmer S., Schmetz D., Guiot C., Vandenbergh D., Allaer D., Rossius M., Chappuis G., Dina D., et al., Nucleotide sequence of the bovine viral diarrhoea virus Osloss strain: comparison with related viruses and identification of specific DNA probes in the 5' untranslated region, J. Gen. Virol. (1993) 74:1433-1438 [PubMed].
  17. Elahi S.M., Shen S.H., Talbot B.G., Massie B., Harpin S., Elazhari Y., Recombinant adenoviruses expressing the E2 protein of bovine viral diarrhea virus induce humoral and cellular immune responses, FEMS Microbiol. Lett. (1999) 177:159-166 [PubMed].
  18. Elouahabi A., Thiry M., Pector V., Ruysschaert J.M., Vandenbranden M., Calorimetry of cationic liposome-DNA complex and intracellular visualization of the complexes, Methods Enzymol. (2003) 373:313-332 [PubMed].
  19. Gallei A., Orlich M., Thiel H.-J., Becher P., Noncytopathogenic pestivirus strains generated by nonhomologous recombination: alterations in the NS4A/NS4B coding region, J. Virol. (2005) 79:14261-14270 [CrossRef] [PubMed].
  20. Gregory D., Tascon R.E., Lowrie D.B., Repeated use of Qiagen columns in large-scale preparation of plasmid DNA, in: Lowrie D.B., Whalen R.G. (Eds.), Methods in molecular medicine, vol. 29, DNA vaccines: methods and protocols, Humana Press Inc., Totowa, NJ, 2000.
  21. Grigera P.R., Marzocca M.P., Capozzo A.V., Buonocore L., Donis R.O., Rose J.K., Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice, Virus Res. (2000) 69:3-15 [CrossRef] [PubMed].
  22. Haas J., Park E.C., Seed B., Codon usage limitation in the expression of HIV-1 envelope glycoprotein, Curr. Biol. (1996) 6:315-324 [CrossRef] [PubMed].
  23. Hamers C., Couvreur B., Dehan P., Letellier C., Lewalle P., Pastoret P.-P., Kerkhofs P., Differences in experimental virulence of bovine viral diarrhoea viral strains isolated from haemorrhagic syndromes, Vet. J. (2000) 160:250-258 [CrossRef] [PubMed].
  24. Hamers C., Couvreur B., Dehan P., Letellier C., Fischer L., Brun A.J., Lewalle P., Michaux C., Kerkhofs P., Pastoret P.-P., Assessment of clinical and virological protection afforded by an inactivated BVDV-1 commercial vaccine against a BVDV-2 challenge, Vet. Rec. (2003) 153:236-240 [PubMed].
  25. Harada T., Tautz N., Thiel H.J., E2-p7 region of the bovine viral diarrhea virus polyprotein: processing and functional studies, J. Virol. (2000) 74:9498-9506 [CrossRef] [PubMed].
  26. Harpin S., Talbot B., Mbikay M., Elazhari Y., Immune response to vaccination DNA encoding the bovine viral diarrhoea virus major glycoprotein gp53 (E2), FEMS Microbiol. Lett. (1997) 146:229-234 [PubMed].
  27. Harpin S., Hurley D., Mbikay M., Talbot B., Elazhari Y., Vaccination of cattle with a DNA plasmid encoding the bovine viral diarrhoea virus major glycoprotein E2, J. Gen. Virol. (1999) 80:3137-3144 [PubMed].
  28. Houe H., Epidemiological features and economical importance of bovine viral diarrhoea virus (BVDV) infections, Vet. Microbiol. (1999) 64:89-107 [CrossRef] [PubMed].
  29. Howard C.J., Clarke M.C., Sopp P., Brownlie J., Immunity to bovine virus diarrhoea virus in calves: the role of different T-cell subpopulations analysed by specific depletion in vivo with monoclonal antibodies, Vet. Immunol. Immunopathol. (1992) 32:303-314 [PubMed].
  30. Howard C.J., Clarke M.C., Brownlie J., Protection against respiratory infection with bovine virus diarrhoea virus by passively acquired antibody, Vet. Microbiol. (1989) 19:195-203 [CrossRef] [PubMed].
  31. Jones L.R., Weber L., Homologous recombination in bovine pestiviruses: Phylogenetic and statistic evidence, Infect. Genet. Evol. (2004) 4:335-343 [PubMed].
  32. Kelling C.L., Evolution of bovine viral diarrhea virus vaccines, Vet. Clin. North Am. Food Anim. Pract. (2004) 20:115-129 [PubMed].
  33. Kozak M., The scanning model for translation: an update, J. Cell Biol. (1989) 108:229-241 [CrossRef] [PubMed].
  34. Köhl W., Zimmer G., Greiser-Wilke I., Haas L., Moennig V., Herrler G., The surface glycoprotein E2 of bovine viral diarrhoea virus contains an intracellular localization signal, J. Gen. Virol. (2004) 85:1101-1111 [CrossRef] [PubMed].
  35. Köhl W., Grone A., Moennig V., Herrler G., Expression of the surface glycoprotein E2 of Bovine viral diarrhea virus by recombinant vesicular stomatitis virus, J. Gen. Virol. (2007) 88:157-165 [CrossRef] [PubMed].
  36. Kramps J.A., Magdalena J., Quak J., Weerdmeester K., Kaashoek M.J., Maris-Veldhuis M.A., Rijsewijk F.A., Keil G., van Oirschot J.T., A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1, J. Clin. Microbiol. (1994) 32:2175-2181 [PubMed].
  37. Krogh A., Larsson B., von Heijne G., Sonnhammer E.L.L., Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes, J. Mol. Biol. (2001) 305:567-580 [CrossRef] [PubMed].
  38. Kummerer B.M., Tautz N., Becher P., Thiel H., Meyers G., The genetic basis for cytopathogenicity of pestiviruses, Vet. Microbiol. (2000) 77:117-128 [CrossRef] [PubMed].
  39. Kweon C.H., Yoon Y.D., An S.H., Lee Y.S., Expression of envelope protein (E2) of bovine viral diarrhea virus in insect cells, J. Vet. Med. Sci. (1997) 59:415-419 [CrossRef] [PubMed].
  40. Lee Y.M., Tscherne D.M., Yun S.I., Frolov I., Rice C.M., Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication, J. Virol. (2005) 79:3231-3242 [CrossRef] [PubMed].
  41. Letellier C., Kerkhofs P., Wellemans G., Vanopdenbosch E., Detection and genotyping of bovine diarrhea virus by reverse transcription-polymerase chain amplification of the 5' untranslated region, Vet. Microbiol. (1999) 64:155-167 [CrossRef] [PubMed].
  42. Liang R., Van den Hurk J.V., Zheng C., Yu H., Pontarollo R.A., Babiuk L.A., Van den Hurk S., Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune response, Vaccine (2005) 23:5252-5262 [CrossRef] [PubMed].
  43. Liu M.A., DNA vaccines: a review, J. Intern. Med. (2003) 253:402-410 [PubMed].
  44. Nielsen H., Engelbrecht J., Brunak S., von Heijne G., Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites, Protein Eng. (1997) 10:1-6 [CrossRef].
  45. Nobiron I., Thompson I., Browlie J., Collins M.E., Co-administration of Il-2 enhances antigen-specific immune response with DNA encoding the glycoprotein E2 of bovine diarrhoea virus, Vet. Microbiol. (2000) 76:129-142 [CrossRef] [PubMed].
  46. Nobiron I., Thompson I., Browlie J., Collins M.E., Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune response in mice, Vaccine (2001) 19:4226-4235 [CrossRef] [PubMed].
  47. Nobiron I., Thompson I., Browlie J., Collins M.E., DNA vaccination against bovine diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge, Vaccine (2003) 21:2082-2092 [CrossRef] [PubMed].
  48. Reinman I., Meyers G., Beer M., Trans-complementation of autonomously replicating Bovine viral diarrhea virus replicons with deletion in the E2 coding region, Virology (2003) 307:213-227 [CrossRef] [PubMed].
  49. Ridpath J.F., Bolin S.R., The genomic sequence of a virulent bovine viral diarrhea virus (BVDV) from the type 2 genotype: detection of a large genomic insertion in a noncytopathic BVDV, Virology (1995) 212:39-46 [CrossRef] [PubMed].
  50. Ridpath J.F., Neill J.D., Frey M., Landgraf J.G., Phylogenetic, antigenic and clinical characterization of type 2 BVDV from North America, Vet. Microbiol. (2000) 77:145-155 [CrossRef] [PubMed].
  51. Rümenapf T., Unger G., Strauss J.H., Thiel H.J., Processing of the envelope glycoproteins of pestiviruses, J. Virol. (1993) 67:3288-3294 [PubMed].
  52. Schmitt J., Becher P., Thiel H.J., Keil G.M., Expression of bovine viral diarrhoea virus glycoprotein E2 by bovine herpesvirus-1 from a synthetic ORF and incorporation of E2 into recombinant virions, J. Gen. Virol. (1999) 80:2839-2848 [PubMed].
  53. Tajima M., The prevalent genotypes of bovine viral diarrhea virus in Japan, Germany and the United States of America, Jpn J. Vet. Res. (2006) 54:129-134 [PubMed].
  54. Toussaint J.F., Coen L., Letellier C., Dispas M., Gillet L., Vanderplasschen A., Kerkhofs P., Genetic immunisation of cattle against bovine herpesvirus 1: glycoprotein gD confers higher protection than glycoprotein gC or tegument protein VP8, Vet. Res. (2005) 36:529-544 [CrossRef] [PubMed] [EDP Sciences].
  55. Toussaint J.F., Letellier C., Paquet D., Dispas M., Kerkhofs P., Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1, Vaccine (2005) 23:5073-5081 [CrossRef] [PubMed].
  56. Van Regenmortel M.H.V., Fauquet C.M., Bishop E.B., Carstens E.B., Estes M.K., Lemon S.M., Maniloff J., Mayo M.A., McGeoch D.J., Pringle C.R., Wickner R.B., Virus taxonomy: classification and nomenclature of viruses, Seventh report of the International Committee on taxonomy of viruses, Academic Press, San Diego, 2000.
  57. Vilcek S., Durkovic B., Kolesarova M., Paton D.J., Genetic diversity of BVDV: consequences for classification and molecular epidemiology, Prev. Vet. Med. (2005) 72:31-35 [CrossRef] [PubMed].
  58. Wang L., Sunyer J.O., Bello L.J., Fusion to C3d enhances the immunogenicity of the E2 glycoprotein of type 2 bovine diarrhea virus, J. Virol. (2004) 78:1616-1622 [CrossRef] [PubMed].
  59. Wang S., Farfan-Arribas D.J., Shen S., Chou T.H., Hirsch A., He F., Lu S., Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine, Vaccine (2006) 24:4531-4540 [CrossRef] [PubMed].